Skip to content
Study details
Enrolling now

Fecal Microbiota Transplantation for Cancer-Related Diarrhea

M.D. Anderson Cancer Center
NCT IDNCT04038619ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1

Target enrollment

40

Study length

about 4.9 years

Ages

18+

Locations

1 site in TX

What this study is about

This trial is testing if fecal microbiota transplantation can help treat diarrhea or colitis caused by certain cancer medications in patients with genitourinary cancers. The treatment involves transplanting healthy bacteria from another person's stool into the patient's gut.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Loperamide
  • 2.Undergo Fecal Microbiota Transplantation

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

loperamide (Opioid receptor agonist in gut; slows intestinal movement)

Endpoints

Primary: Incidence of fecal microbiota transplantation (FMT)-related adverse events

Body systems

Oncology, Gastroenterology